| 2.37 -0.03 (-1.25%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.95 |
1-year : | 3.44 |
| Resists | First : | 2.52 |
Second : | 2.95 |
| Pivot price | 1.99 |
|||
| Supports | First : | 1.99 |
Second : | 1.65 |
| MAs | MA(5) : | 2.29 |
MA(20) : | 1.97 |
| MA(100) : | 2.78  |
MA(250) : | 3.25 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 86.2 |
D(3) : | 84.3 |
| RSI | RSI(14): 64 |
|||
| 52-week | High : | 6.23 | Low : | 1.29 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SNES ] has closed below upper band by 10.1%. Bollinger Bands are 25.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.53 - 2.54 | 2.54 - 2.56 |
| Low: | 2.27 - 2.29 | 2.29 - 2.3 |
| Close: | 2.35 - 2.37 | 2.37 - 2.39 |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Thu, 19 Feb 2026
Glenbrook Capital buys SenesTech (SNES) shares worth $200,634 By Investing.com - Investing.com UK
Wed, 18 Feb 2026
Rat birth control bait cuts city tracking plate readings by 79–88% - Stock Titan
Tue, 10 Feb 2026
Non-lethal rat control maker brings Amazon sales in-house to lift margins - Stock Titan
Fri, 06 Feb 2026
Glenbrook Capital buys SenesTech (SNES) shares worth $15k By Investing.com - Investing.com Canada
Mon, 02 Feb 2026
SenesTech's Evolve® Approved in New Zealand - ChartMill
Mon, 02 Feb 2026
New Zealand's $4.5B predator plan adds rat birth control tool - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 5 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 4.2 (%) |
| Held by Institutions | 11 (%) |
| Shares Short | 13 (K) |
| Shares Short P.Month | 39 (K) |
| EPS | -2.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.17 |
| Profit Margin | -253.6 % |
| Operating Margin | -195.3 % |
| Return on Assets (ttm) | -38.6 % |
| Return on Equity (ttm) | -77.8 % |
| Qtrly Rev. Growth | 43.2 % |
| Gross Profit (p.s.) | 0.27 |
| Sales Per Share | 0.44 |
| EBITDA (p.s.) | -1.1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -1.08 |
| PEG Ratio | 0 |
| Price to Book value | 1.09 |
| Price to Sales | 5.37 |
| Price to Cash Flow | -2.34 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|